Michael A. Olaopa, Ph.D.
AeroLeads people directory · profile

Michael A. Olaopa, Ph.D. Email & Phone Number

Associate Director, Research Lead at Spark Therapeutics, Inc., a Member of Roche at Spark Therapeutics, Inc.
Location: Philadelphia, Pennsylvania, United States 9 work roles 4 schools
1 work email found @phenovista.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email m****@phenovista.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Spark Therapeutics, Inc.
Role
Associate Director, Research Lead at Spark Therapeutics, Inc., a Member of Roche
Location
Philadelphia, Pennsylvania, United States
Company size
508 employees

Who is Michael A. Olaopa, Ph.D.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Michael A. Olaopa, Ph.D. is listed as Associate Director, Research Lead at Spark Therapeutics, Inc., a Member of Roche at Spark Therapeutics, Inc., a company with 508 employees, based in Philadelphia, Pennsylvania, United States. AeroLeads shows a work email signal at phenovista.com and a matched LinkedIn profile for Michael A. Olaopa, Ph.D..

Michael A. Olaopa, Ph.D. previously worked as Associate Director, Research Lead | Systemic Gene Therapy at Spark Therapeutics, Inc. and Senior Project Lead at Phenovista Biosciences. Michael A. Olaopa, Ph.D. holds Phd, Medical And Molecular Genetics from Indiana University School Of Medicine.

Company email context

Email format at Spark Therapeutics, Inc.

This section adds company-level context without repeating Michael A. Olaopa, Ph.D.'s masked contact details.

*@phenovista.com
68% confidence

AeroLeads found 1 current-domain work email signal for Michael A. Olaopa, Ph.D.. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Michael A. Olaopa, Ph.D.

With a proven track record of independent and cross-functional collaborations, Michael works closely with Key Opinion Leaders (KOLs) and Healthcare Providers (HCPs) to uncover molecular targets responsible for genetic diseases. This approach involves not only identifying these targets but also elucidating the novel biological and genetic mechanisms underlying their function. This work drives the development of tailored pre-clinical therapeutic strategies aimed at restoring normal function.Core Strengths:Problem-Solving & Adaptability: Leveraging a multidisciplinary approach to tackle complex challenges in biomedical research.Simplification & Communication: Skilled at distilling highly complex scientific concepts into accessible information for diverse audiences.KOL Engagement: Building strong, value-driven relationships with KOLs based on active listening, mutual respect, and a commitment to generating impactful results.Beyond Work:Michael is passionate about giving back through mentorship and public speaking, contributing as a scientific journal reviewer, and teaching through martial arts. He also engages in fundraising for medical-related causes. In his free time, he avidly enjoys astrophotography and occasionally grows butterflies.

Listed skills include Genetic Engineering, Project Management, Assay Development, Kol Management, and 5 others.

Current workplace

Michael A. Olaopa, Ph.D.'s current company

Company context helps verify the profile and gives searchers a useful next step.

Spark Therapeutics, Inc.
Spark Therapeutics, Inc.
Associate Director, Research Lead at Spark Therapeutics, Inc., a Member of Roche
Philadelphia, Pennsylvania, United States
Website
sparktx.com
Employees
508
AeroLeads page
Company profile
View company profile Email format
9 roles

Michael A. Olaopa, Ph.D. work experience

A career timeline built from the work history available for this profile.

Associate Director, Research Lead | Systemic Gene Therapy

Current
Spark Therapeutics, Inc.

Philadelphia, PA, US

  • Role Overview:
  • Portfolio and Clinical Trial Support: Provide non-clinical expertise for assets in the portfolio, focusing on Phase I/II clinical trials.
  • Team Leadership: Lead high-performing teams in a deadline-driven environment, ensuring achievement of critical milestones and deliverables.
  • External Collaboration: Engage with Key Opinion Leaders (KOLs) and Subject Matter Experts (SMEs) to harness external resources and specialized knowledge.
  • Research and Development Guidance: Direct research and IND-enabling activities to advance candidates from pre-portfolio stages into the portfolio.Core Competencies:
  • Clinical Biomarker Strategy: Inform and refine clinical biomarker strategies to optimize therapeutic outcomes.
Apr 2022 - Present

Senior Project Lead

Phenovista Biosciences

San Diego, California, US

Michael led engagements with external KOLs and SMEs in biotech and pharma to develop, implement, and communicate tailored high-content in vitro assays for screening small molecules, monoclonal antibodies, and test-articles. Over a 20-month period, he collaborated with stakeholders to achieve research milestones and managed key client accounts with a.

Oct 2021 - Apr 2022

Project Lead

Phenovista Biosciences

San Diego, California, US

Leadership: KOL Engagement; Client Relationship Building; Project Management. Therapeutic Areas: Cardiovascular, Neuroscience, Liver, Oncology, Gene Therapy.Technical: In-Vitro Assay Development (iPSC / Stem Cells, Primary Cells); High Content Screening and Imaging Analyses; Spheroid and 3D Organoid Cell Modeling; Cell Painting; In Vitro Pharmacology and.

Sep 2020 - Sep 2021

Project Scientist | Neurocardiology Center For Excellence

Ucla Health

Los Angeles, CA, US

Michael collaborated with HCPs to build pre-clinical models of cardiovascular failure, which could quantify neurological, physiological, and functional alterations that occur in the cardiac conduction system after a myocardial infarction (heart attack).Publication:"Heterogeneous cardiac sympathetic innervation gradients promote arrhythmogenesis in murine.

Jun 2018 - Jun 2019

Staff Scientist | Knight Cardiovascular Institute

Oregon Health And Science University

Portland, Oregon, US

Michael conceptualized and led a collaborative study to assess the effects of a novel small molecule on the cardiac sodium ion channel and heart function. This small molecule is currently being developed as a therapeutic against triple-negative breast cancer by interacting with Lamin-A/C, a protein that Michael et al. had previously shown to be important.

Sep 2016 - Apr 2018

Research Scholar | Krannert Institute Of Cardiology At Methodist Hospital

Indiana University Health

Indianapolis, Indiana, US

Michael designed and performed functional cardiac electrophysiology studies that delineated the underlying role of novel LMNA (Lamin-A/C) and SCN5A (Nav1.5) genetic mutations in patients with cardiac arrhythmias often associated with dilated cardiomyopathy (heart failure). In 2015, Michael was invited to present the findings of his research at both the.

Oct 2012 - Sep 2016

Graduate Research Assistant | Herman B. Wells Center For Pediatrics At Riley Children'S Hospital

Indiana University School Of Medicine

Indianapolis, IN, US

Michael designed 3 novel pre-clinical therapeutic approaches, which targeted the beta-adrenergic and MAPK pathways, respectively, using 2 models of congenital heart disease in newborn patients. The results of this research led to an Excellence in Science Award (2010) from the American Association for the Advancement of Sciences (AAAS), including an Invited.

Aug 2005 - Jan 2011
Team & coworkers

Colleagues at Spark Therapeutics, Inc.

Other employees you can reach at sparktx.com. View company contacts for 508 employees →

DB Dana B. Dana B. Colleague at Spark Therapeutics, Inc.Jackson Township, New Jersey, United States, United States View → CK Colleen Kovacsics, Phd, Rbp (Absa) Colleen Kovacsics, Phd, Rbp (Absa) Colleague at Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States, United States View → EM Eric Martis Eric Martis Colleague at Spark Therapeutics, Inc.Kingston, Pennsylvania, United States, United States View → DB Danya Brittingham Danya Brittingham Colleague at Spark Therapeutics, Inc.Atlanta, Georgia, United States, United States View → S( Sharonette (Sharone) Cannon Sharonette (Sharone) Cannon Colleague at Spark Therapeutics, Inc.Greater Philadelphia, United States View → AD Anthony Dos Santos Anthony Dos Santos Colleague at Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States, United States View → CA Charmaine Azutillo Charmaine Azutillo Colleague at Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States, United States View → SO Shannon O'Neill Shannon O'Neill Colleague at Spark Therapeutics, Inc.Greater Philadelphia, United States View → MA Mary Ault Mary Ault Colleague at Spark Therapeutics, Inc.Hatfield, Pennsylvania, United States, United States View → CS Chris Stevens Chris Stevens Colleague at Spark Therapeutics, Inc.Paoli, Pennsylvania, United States, United States View →
4 education records

Michael A. Olaopa, Ph.D. education

Phd, Medical And Molecular Genetics

Indiana University School Of Medicine

Mba-Level Postgraduate Certificate, Business Of Life Sciences

Indiana University - Kelley School Of Business

Bs, Cells, Molecules, And Systems Biology

Berea College

Ssce

Grace High School, Lagos, Nigeria
FAQ

Frequently asked questions about Michael A. Olaopa, Ph.D.

Quick answers generated from the profile data available on this page.

What company does Michael A. Olaopa, Ph.D. work for?

Michael A. Olaopa, Ph.D. works for Spark Therapeutics, Inc..

What is Michael A. Olaopa, Ph.D.'s role at Spark Therapeutics, Inc.?

Michael A. Olaopa, Ph.D. is listed as Associate Director, Research Lead at Spark Therapeutics, Inc., a Member of Roche at Spark Therapeutics, Inc..

What is Michael A. Olaopa, Ph.D.'s email address?

AeroLeads has found 1 work email signal at @phenovista.com for Michael A. Olaopa, Ph.D. at Spark Therapeutics, Inc..

Where is Michael A. Olaopa, Ph.D. based?

Michael A. Olaopa, Ph.D. is based in Philadelphia, Pennsylvania, United States while working with Spark Therapeutics, Inc..

What companies has Michael A. Olaopa, Ph.D. worked for?

Michael A. Olaopa, Ph.D. has worked for Spark Therapeutics, Inc., Phenovista Biosciences, Ucla Health, Oregon Health And Science University, and Indiana University Health.

Who are Michael A. Olaopa, Ph.D.'s colleagues at Spark Therapeutics, Inc.?

Michael A. Olaopa, Ph.D.'s colleagues at Spark Therapeutics, Inc. include Dana B., Colleen Kovacsics, Phd, Rbp (Absa), Eric Martis, Danya Brittingham, and Sharonette (Sharone) Cannon.

How can I contact Michael A. Olaopa, Ph.D.?

You can use AeroLeads to view verified contact signals for Michael A. Olaopa, Ph.D. at Spark Therapeutics, Inc., including work email, phone, and LinkedIn data when available.

What schools did Michael A. Olaopa, Ph.D. attend?

Michael A. Olaopa, Ph.D. holds Phd, Medical And Molecular Genetics from Indiana University School Of Medicine.

What skills is Michael A. Olaopa, Ph.D. known for?

Michael A. Olaopa, Ph.D. is listed with skills including Genetic Engineering, Project Management, Assay Development, Kol Management, Communication, Client Relations, Molecular And Cellular Biology, and Commercialization.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.